New drug combo shows promise for Hard-to-Treat GI cancers
NCT ID NCT07280377
First seen Jan 10, 2026 · Last updated May 20, 2026 · Updated 18 times
Summary
This study is testing a combination of two drugs, pelareorep and atezolizumab, in people with advanced or metastatic gastrointestinal cancers like anal and pancreatic cancer. The goal is to see if the combination is safe and can shrink tumors or slow disease progression. About 122 participants will receive the treatment, and researchers will also look for biomarkers that might predict who benefits most.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE PANCREATIC CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asklepios Kliniken Hamburg GmbH
Hamburg, Free and Hanseatic City of Hamburg, 22763, Germany
-
Caritasklinikum Saarbrücken St. Theresia
Saarbrücken, Saarland, 66113, Germany
-
Charité Universitätsklinikum Berlin
Berlin, State of Berlin, 13353, Germany
-
Gemeinschaftspraxis Dr. Med Bernhard Heinreich
Augsburg, Bavaria, 86150, Germany
-
Hämatologisch-Onkologische Praxis Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, 20249, Germany
-
Klinikum Chemnitz gGmbH
Chemnitz, Saxony, 09116, Germany
-
Klinikum der Universität München
München, Bavaria, 81377, Germany
-
Krankenhaus Nordwest
Frankfurt am Main, Hesse, 60488, Germany
-
Nationales Centrum für Tumorerkrankungen Heidelberg
Heidelberg, Baden-Wurttemberg, 69120, Germany
-
SLK-Kliniken Heilbronn GmbH
Heilbronn, Baden-Wurttemberg, 74078, Germany
-
St. Josef-Hospìtal, Bochum
Bochum, North Rhine-Westphalia, 44791, Germany
-
Universität Leipzig
Leipzig, Saxony, 04103, Germany
-
Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, 72076, Germany
-
Universitätsklinikum Ulm
Ulm, Baden-Wurttemberg, 89081, Germany
-
Universitätsmedizin Mainz
Mainz, Rhineland-Palatinate, 55131, Germany
Conditions
Explore the condition pages connected to this study.